Differential effects of some novel synthetic oestrogen analogs on oxidative PC12 cell death caused by serum deprivation

References

• Levin ER. Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol 2005;19:1951–1959.
   PubMed Web of Science ®Google Scholar
• Vasudevan N, Pfaff DW. Membrane-initiated actions of estrogens in neuroendocrinology: emerging principles. Endocr Rev 2007;28:1–19.
   PubMed Web of Science ®Google Scholar
• Schreihofer DA, Ma Y. Estrogen receptors and ischemic neuroprotection: who, what, where, and when? Brain Res 2013;1514:107–122.
   PubMed Web of Science ®Google Scholar
• Bessa A, Campos FL, Videira RA, Mendes-Oliveira J, Bessa-Neto D, Baltazar G. GPER: A new tool to protect dopaminergic neurons? Biochim Biophys Acta 2015;1852:2035–2041.
   PubMed Web of Science ®Google Scholar
• Lebesgue D, Traub M, De Butte-Smith M, Chen C, Zukin RS, Kelly MJ, et al. Acute administration of non-classical estrogen receptor agonists attenuates ischemia-induced hippocampal neuron loss in middle-aged female rats. PLoS One 2010;5:e8642.
   PubMed Web of Science ®Google Scholar
• Tang H, Zhang Q, Yang L, Dong Y, Khan M, Yang F, et al. Reprint of “GPR30 mediates estrogen rapid signaling and neuroprotection”. Mol Cell Endocrinol 2014;389:92–98.
   PubMed Web of Science ®Google Scholar
• Gingerich S, Kim GL, Chalmers JA, Koletar MM, Wang X, Wang Y, et al. Estrogen receptor alpha and G-protein coupled receptor 30 mediate the neuroprotective effects of 17beta-estradiol in novel murine hippocampal cell models. Neuroscience 2010;170:54–66.
   PubMed Web of Science ®Google Scholar
• Simpkins JW, Richardson TE, Yi KD, Perez E, Covey DF. Neuroprotection with non-feminizing estrogen analogues: an overlooked possible therapeutic strategy. Horm Behav 2013;63:278–283.
   PubMed Web of Science ®Google Scholar
• Petrone AB, Gatson JW, Simpkins JW, Reed MN. Non-feminizing estrogens: a novel neuroprotective therapy. Mol Cell Endocrinol 2014;389:40–47.
   PubMed Web of Science ®Google Scholar
• Bansal R, Singh R. Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: a literature review. Med Res Rev 2017 [Jul 11]. DOI:10.1002/med.21458
   Web of Science ®Google Scholar
• Engler-Chiurazzi EB, Brown CM, Povroznik JM, Simpkins JW. Estrogens as neuroprotectants: estrogenic actions in the context of cognitive aging and brain injury. Prog Neurobiol 2017;157:188–211.
   PubMed Web of Science ®Google Scholar
• Manoharan S, Guillemin GJ, Abiramasundari RS, Essa MM, Akbar M, Akbar MD. The role of reactive oxygen species in the pathogenesis of Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease: a mini review. Oxid Med Cell Longev 2016;2016:8590578.
   PubMed Web of Science ®Google Scholar
• Simpkins JW, Dykens JA. Mitochondrial mechanisms of estrogen neuroprotection. Brain Res Rev 2008;57:421–430.
   PubMedGoogle Scholar
• Dykens JA, Moos WH, Howell N. Development of 17α-estradiol as a neuroprotective therapeutic agent: rationale and results from a phase I clinical study. Ann N Y Acad Sci 2005;1052:116–135.
   PubMed Web of Science ®Google Scholar
• Rakkestad KE, Sørvik IB, Øverby GR, Debernard KAB, Mathisen GH, Paulsen RE. 17α-estradiol down-regulates glutathione synthesis in serum deprived PC-12 cells. Free Radic Res 2014;48:1170–1178.
   PubMed Web of Science ®Google Scholar
• Gupta A, Kumar BS, Negi AS. Current status on development of steroids as anticancer agents. J Steroid Biochem Mol Biol 2013;137:242–270.
   PubMed Web of Science ®Google Scholar
• Berg D, Sonsalla R, Kuss E. Concentrations of 2-methoxyoestrogens in human serum measured by a heterologous immunoassay with an 125I-labelled ligand. Acta Endocrinol (Copenh) 1983;103:282–288.
   PubMedGoogle Scholar
• Kumar BS, Raghuvanshi DS, Hasanain M, Alam S, Sarkar J, Mitra K, et al. Recent Advances in chemistry and pharmacology of 2-methoxyestradiol: an anticancer investigational drug. Steroids 2016;110:9–34.
   PubMed Web of Science ®Google Scholar
• Solum EJ, Cheng JJ, Sørvik IB, Paulsen RE, Vik A, Hansen TV. Synthesis and biological evaluations of new analogs of 2-methoxyestradiol: inhibitors of tubulin and angiogenesis. Eur J Med Chem 2014;85:391–398.
   PubMed Web of Science ®Google Scholar
• Solum EJ, Akselsen ØW, Vik A, Hansen TV. Synthesis and pharmacological effects of the anti-cancer Agent 2-methoxyestradiol. Curr Pharm Des 2015;21:5453–5466.
   PubMed Web of Science ®Google Scholar
• Lindenboim L, Diamond R, Rothenberg E, Stein R. Apoptosis induced by serum deprivation of PC12 cells is not preceded by growth arrest and can occur at each phase of the cell cycle. Cancer Res 1995;55:1242–1247.
   PubMed Web of Science ®Google Scholar
• Liu H, Nowak R, Chao W, Bloch KD. Nerve growth factor induces anti-apoptotic heme oxygenase-1 in rat pheochromocytoma PC12 cells. J Neurochem 2003;86:1553–1563.
   PubMed Web of Science ®Google Scholar
• Calderón FH, Bonnefont A, Muñoz FJ, Fernandez V, Videla LA, Inestrosa NC. PC12 and neuro 2a cells have different susceptibilities to acetylcholinesterase-amyloid complexes, amyloid25-35 fragment, glutamate, and hydrogen peroxide. J Neurosci Res 1999;56:620–631.
   PubMed Web of Science ®Google Scholar
• Habauzit D, Flouriot G, Pakdel F, Saligaut C. Effects of estrogens and endocrine-disrupting chemicals on cell differentiation-survival-proliferation in brain: contributions of neuronal cell lines. J Toxicol Environ Health B Crit Rev 2011;14:300–327.
   PubMed Web of Science ®Google Scholar
• Franco R, Cidlowski JA. Apoptosis and glutathione: beyond an antioxidant. Cell Death Differ 2009;16:1303–1314.
   PubMed Web of Science ®Google Scholar
• Misra I, Griffith OW. Expression and purification of human gamma-glutamylcysteine synthetase. Protein Expr Purif 1998;13:268–276.
   PubMed Web of Science ®Google Scholar
• Lu SC. Regulation of glutathione synthesis. Mol Aspects Med 2009;30:42–59.
   PubMed Web of Science ®Google Scholar
• Franklin CC, Backos DS, Mohar I, White CC, Forman HJ, Kavanagh TJ. Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Mol Aspects Med 2009;30:86–98.
   PubMed Web of Science ®Google Scholar
• Huseby NE, Ravuri C, Moens U. The proteasome inhibitor lactacystin enhances GSH synthesis capacity by increased expression of antioxidant components in an Nrf2-independent, but p38 MAPK-dependent manner in rat colorectal carcinoma cells. Free Radic Res 2016;50:1–13.
   PubMed Web of Science ®Google Scholar
• Kuwano T, Watanabe M, Kagawa D, Murase T. Hydrolyzed methylhesperidin induces antioxidant enzyme expression via the Nrf2-ARE pathway in normal human epidermal keratinocytes. J Agric Food Chem 2015;63:7937–7944.
   PubMed Web of Science ®Google Scholar
• Koyani CN, Kitz K, Rossmann C, Bernhart E, Huber E, Trummer C, et al. Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death. Biochem Pharmacol 2016;104:29–41.
   PubMed Web of Science ®Google Scholar
• Gu L, Tao X, Xu Y, Han X, Qi Y, Xu L, et al. Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated inhibition of p38 MAPK pathway. Toxicol Appl Pharmacol 2016;292:19–29.
   PubMed Web of Science ®Google Scholar
• Zarubin T, Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res 2005;15:11–18.
   PubMed Web of Science ®Google Scholar
• Akselsen ØW, Hansen TV. Ortho-formylation of estrogens. Synthesis of the anti-cancer agent 2-methoxyestradiol. Tetrahedron 2011;67:7738–7742.
   Web of Science ®Google Scholar
• Paulsen RE, Weaver CA, Fahrner TJ, Milbrandt J. Domains regulating transcriptional activity of the inducible orphan receptor NGFI-B. J Biol Chem 1992;267:16491–16496.
   PubMed Web of Science ®Google Scholar
• Slagsvold HH, Rosseland CM, Jacobs C, Khuong E, Kristoffersen N, Gaarder M, et al. High molecular weight DNA fragments are processed by caspase sensitive or caspase independent pathways in cultures of cerebellar granule neurons. Brain Res 2003;984:111–121.
   PubMed Web of Science ®Google Scholar
• Sørvik IB, Paulsen RE. High and low concentration of 17α-estradiol protect cerebellar granule neurons in different time windows. Biochem Biophys Res Commun 2017;490:676–681.
   PubMed Web of Science ®Google Scholar
• Fallgren AB, Mathisen GH, Maehlen J, Blomhoff R, Paulsen RE. Preconditioning with estradiol abolishes its neuroprotection in cerebellar neurons. Biochem Biophys Res Commun 2007;352:966–972.
   PubMed Web of Science ®Google Scholar
• Dennis MK, Field AS, Burai R, Ramesh C, Petrie WK, Bologa CG, et al. Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity. J Steroid Biochem Mol Biol 2011;127:358–366.
   PubMed Web of Science ®Google Scholar
• Satoh T, Sakai N, Enokido Y, Uchiyama Y, Hatanaka H. Survival factor-insensitive generation of reactive oxygen species induced by serum deprivation in neuronal cells. Brain Res 1996;733:9–14.
   PubMed Web of Science ®Google Scholar
• Wang R, Yang J, Peng L, Zhao J, Mu N, Huang J, et al. Gardenamide A attenuated cell apoptosis induced by serum deprivation insult via the ERK1/2 and PI3K/AKT signaling pathways. Neuroscience 2015;286:242–250.
   PubMed Web of Science ®Google Scholar
• Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996;271:C1424–C1437.
   PubMed Web of Science ®Google Scholar
• Wen J, Li H, Zhang Y, Li X, Liu F. Modification of HSP proteins and Ca2+ are responsible for the NO-derived peroxynitrite mediated neurological damage in PC12 cell. Int J Clin Exp Pathol 2015;8:4492–4502.
   PubMed Web of Science ®Google Scholar
• Estévez AG, Radi R, Barbeito L, Shin JT, Thompson JA, Beckman JS. Peroxynitrite-induced cytotoxicity in PC12 cells: evidence for an apoptotic mechanism differentially modulated by neurotrophic factors. J Neurochem 1995;65:1543–1550.
   PubMed Web of Science ®Google Scholar
• Hou Y, Wang Y, Wang H, Xu Y. Induction of glutathione synthesis in human hepatocytes by acute and chronic arsenic exposure: differential roles of mitogen-activated protein kinases. Toxicology 2014;325:96–106.
   PubMed Web of Science ®Google Scholar
• Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997;138:863–870.
   PubMed Web of Science ®Google Scholar
• Viña J, Sastre J, Pallardó FV, Gambini J, Borras C. Role of mitochondrial oxidative stress to explain the different longevity between genders: protective effect of estrogens. Free Radic Res 2006;40:1359–1365.
   PubMed Web of Science ®Google Scholar
• Alexaki VI, Charalampopoulos I, Kampa M, Nifli AP, Hatzoglou A, Gravanis A, et al. Activation of membrane estrogen receptors induce pro-survival kinases. J Steroid Biochem Mol Biol 2006;98:97–110.
   PubMed Web of Science ®Google Scholar
• Kooy NW, Royall JA, Ischiropoulos H, Beckman JS. Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Radic Biol Med 1994;16:149–156.
   PubMed Web of Science ®Google Scholar
• Henderson LM, Chappell JB. Dihydrorhodamine 123: a fluorescent probe for superoxide generation? Eur J Biochem 1993;217:973–980.
   PubMedGoogle Scholar
• Stander BA, Marais S, Vorster CJ, Joubert AM. In vitro effects of 2-methoxyestradiol on morphology, cell cycle progression, cell death and gene expression changes in the tumorigenic MCF-7 breast epithelial cell line. J Steroid Biochem Mol Biol 2010;119:149–160.
   PubMed Web of Science ®Google Scholar
• Kato S, Sadarangani A, Lange S, Delpiano AM, Vargas M, Branes J, et al. 2-Methoxyestradiol mediates apoptosis through caspase-dependent and independent mechanisms in ovarian cancer cells but not in normal counterparts. Reprod Sci 2008;15:878–894.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Ma Y, Cheng YF, Li WJ, Zhang Z, Chen SY. Involvement of reactive oxygen species in 2-methoxyestradiol-induced apoptosis in human neuroblastoma cells. Cancer Lett 2011;313:201–210.
   PubMed Web of Science ®Google Scholar
• Gallina AA, Palumbo A, Casotti R. Oxidative pathways in response to polyunsaturated aldehydes in the marine diatom Skeletonema marinoi (Bacillariophyceae). J Phycol 2016;52:590–598.
   PubMed Web of Science ®Google Scholar
• Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005;307:1625–1630.
   PubMed Web of Science ®Google Scholar
• Meyer MR, Fredette NC, Howard TA, Hu C, Ramesh C, Daniel C, et al. G protein-coupled estrogen receptor protects from atherosclerosis. Sci Rep 2014;4:7564.
   PubMed Web of Science ®Google Scholar
• Prossnitz ER, Barton M. Estrogen biology: new insights into GPER function and clinical opportunities. Mol Cell Endocrinol 2014;389:71–83.
   PubMed Web of Science ®Google Scholar
• Meyer MR, Fredette NC, Daniel C, Sharma G, Amann K, Arterburn JB, et al. Obligatory role for GPER in cardiovascular aging and disease. Sci Signal 2016;9:ra105.
   PubMed Web of Science ®Google Scholar
• Pan X, Yan D, Wang D, Wu X, Zhao W, Lu Q, et al. Mitochondrion-mediated apoptosis induced by acrylamide is regulated by a balance between Nrf2 antioxidant and MAPK signaling pathways in PC12 cells. Mol Neurobiol 2017;54:4781–4794.
   PubMed Web of Science ®Google Scholar
• Raza H, John A, Brown EM, Benedict S, Kambal A. Alterations in mitochondrial respiratory functions, redox metabolism and apoptosis by oxidant 4-hydroxynonenal and antioxidants curcumin and melatonin in PC12 cells. Toxicol Appl Pharmacol 2008;226:161–168.
   PubMed Web of Science ®Google Scholar
• Singh SV, Srivastava SK, Choi S, Lew KL, Antosiewicz J, Xiao D, et al. Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. J Biol Chem 2005;280:19911–19924.
   PubMed Web of Science ®Google Scholar
• Kachadourian R, Day BJ. Flavonoid-induced glutathione depletion: potential implications for cancer treatment. Free Radic Biol Med 2006;41:65–76.
   PubMed Web of Science ®Google Scholar
• Voshavar C, Shah M, Xu L, Dutta AK. Assessment of protective role of multifunctional dopamine agonist D-512 against oxidative stress produced by depletion of glutathione in PC12 cells: implication in neuroprotective therapy for Parkinson’s disease. Neurotox Res 2015;28:302–318.
   PubMed Web of Science ®Google Scholar
• Froissard P, Monrocq H, Duval D. Role of glutathione metabolism in the glutamate-induced programmed cell death of neuronal-like PC12 cells. Eur J Pharmacol 1997;326:93–99.
   PubMed Web of Science ®Google Scholar
• Holmström KM, Kostov RV, Dinkova-Kostova AT. The multifaceted role of Nrf2 in mitochondrial function. Curr Opin Toxicol 2016;1:80–91.
   PubMedGoogle Scholar
• Cullinan SB, Gordan JD, Jin J, Harper JW, Diehl JA. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol Cell Biol 2004;24:8477–8486.
   PubMed Web of Science ®Google Scholar
• Ochi T. Hydrogen peroxide increases the activity of gamma-glutamylcysteine synthetase in cultured Chinese hamster V79 cells. Arch Toxicol 1995;70:96–103.
   PubMed Web of Science ®Google Scholar
• Ochi T. Menadione causes increases in the level of glutathione and in the activity of gamma-glutamylcysteine synthetase in cultured Chinese hamster V79 cells. Toxicology 1996;112:45–55.
   PubMed Web of Science ®Google Scholar
• Lan A, Xu W, Zhang H, Hua X, Zheng D, Guo R, et al. Inhibition of ROS-activated p38MAPK pathway is involved in the protective effect of H2S against chemical hypoxia-induced inflammation in PC12 cells. Neurochem Res 2013;38:1454–1466.
   PubMed Web of Science ®Google Scholar
• Jang JH, Surh YJ. AP-1 mediates beta-amyloid-induced iNOS expression in PC12 cells via the ERK2 and p38 MAPK signaling pathways. Biochem Biophys Res Commun 2005;331:1421–1428.
   PubMed Web of Science ®Google Scholar
• Shen M, Shi H. Estradiol and estrogen receptor agonists oppose oncogenic actions of leptin in HepG2 cells. PLoS One 2016;11:e0151455.
   PubMed Web of Science ®Google Scholar